Pacific Biosciences of California, Inc. Derivative Liability
Pacific Biosciences of California, Inc. (PACB) had Derivative Liability of $0 as of 2020-02-29, per its 10-Q filed 2020-08-06.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2020-08-06
- 2020-02-29: Derivative Liability $0.00.
- 2018-12-31: Derivative Liability $16.00K.
- 2017-12-31: Derivative Liability $183.00K.
| Period end | Derivative Liability |
|---|---|
| 2020-02-29 | $0.00 10-Q · filed 2020-08-06 |
| 2018-12-31 | $16.00K 10-K · filed 2020-02-28 |
| 2017-12-31 | $183.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |